Exelixis reported $98.49M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Akebia Therapeutics AKBA:US $ 41.65M 323K
Amgen AMGN:US $ 1.38B 130M
AstraZeneca AZN:LN 2.57B 76M
Bayer BAYN:GR 3.75B 226M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cytokinetics CYTK:US $ 21.2M 5.6M
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eisai 4523:JP 74.73B 4.69B
Eli Lilly And LLY:US $ 1.69B 109.7M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Exelixis EXEL:US $ 98.49M 3.86M
Genmab GEN:DC 264M 63M
Glaxosmithkline GSK:US 2.5B 183M
Immunogen IMGN:US $ 9.73M 481K
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Macrogenics MGNX:US $ 15.23M 198K
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Moderna Inc MRNA:US 121M 44M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Takeda 4502:JP 219.84B 14.55B
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Xencor XNCR:US $ 8.86M 637K
YTE INCY:US $ 168.86M 15.06M